Quidel earlier signed a distribution and fulfilment agreement with McKesson. Credit: fernando zhiminaicela from Pixabay.

The retail partnership will allow Walgreens to make Quidel’s non-prescription QuickVue at-home over-the-counter (OTC) Covid-19 tests available at 7,600 Walgreens stores in the US and Puerto Rico.

Moreover, consumers will also have the option to order the shelf-stable packages online at Walgreens.com for store pick-up or same-day delivery.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Each package contains two of the self-administered rapid antigen tests.

Quidel president and CEO Douglas Bryant said: “This retail collaboration with Walgreens will expedite in-store availability and over-the-counter sales of our QuickVue at-home OTC Covid-19 antigen tests to consumers nationwide.”

Although the QuickVue at-home OTC Covid-19 test has not been approved by the US Food and Drug Administration (FDA), it can be used under the FDA’s emergency use authorisation.

In a press statement, Quidel said: “The QuickVue at-home Covid-19 test shows excellent performance, with positive results agreeing with PCR 83.5% of the time, and negative results agreeing 99.2% of the time, delivering confidence to individuals running the test and helping to prevent asymptomatic virus spread.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Last month, Quidel signed a distribution and fulfilment agreement with McKesson to improve access to the QuickVue at-home OTC COVID-19 test for consumers.

McKesson will serve as the lead commercial partner for Quidel’s at-home OTC COVID-19 rapid antigen test orders.

Using the QuickVue OTC Covid-19 test, consumers can get highly accurate results in ten minutes or less from nasal swab samples, Quidel said.